Oral vaccination with the porcine circovirus type 2 (PCV‐2) capsid protein expressed byLactococcus lactisinduces a specific immune response against PCV‐2 in mice
Authors:
- 1 October 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Applied Microbiology
- Vol. 128 (1) , 74-87
Abstract
Aims PCV2 can cause post‐weaning multi‐systemic wasting syndrome in pigs, which leads to enormous losses in the swine industry worldwide. Here, a genetically engineered Lactococcus strain expressing the main protective antigen of PCV2, the Cap protein, was developed to against PCV2 infection as an oral vaccine. Methods and Results Expression of the Cap protein was confirmed via western blot, ELISA, and fluorescence microscopy. Over 90% of the recombinant pAMJ399‐Cap/MG1363 survived a simulated gastro‐intestinal transit. It also survived the murine intestinal tract for at least 11 days. Then, the safety and immunogenicity of pAMJ399‐Cap/MG1363 in orally immunized mice were evaluated. The levels of the sIgA, IgG, and cytokines (IL‐4 and IFN‐γ) obtained from the mice immunized with pAMJ399‐Cap/MG1363 were significantly higher than those in the control groups. Conclusions pAMJ399‐Cap/MG1363 can survive in the gastro‐intestinal transit and effectively induce mucosal, cellular, and humoral immune response against PCV2 infection via oral administration. Significance and Impact of the study This study demonstrates the potential of the genetically engineered L. lactis as a candidate for an oral vaccine against PCV2.Keywords
This publication has 45 references indexed in Scilit:
- Epidemiology and transmission of porcine circovirus type 2 (PCV2)Virus Research, 2012
- Immunology of porcine circovirus type 2 (PCV2)Virus Research, 2012
- Characterization of a New Disease Syndrome Associated with Porcine Circovirus Type 2 in Previously Vaccinated HerdsJournal of Clinical Microbiology, 2011
- Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccinationVeterinary Microbiology, 2010
- One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental modelVaccine, 2009
- Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2Vaccine, 2008
- Induction of Immune Responses in Mice after Intragastric Administration of Lactobacillus casei Producing Porcine Parvovirus VP2 ProteinApplied and Environmental Microbiology, 2007
- Ileal and jejunal Peyer’s patches play distinct roles in mucosal immunity of sheepImmunology, 1999
- Isolation of Porcine Circovirus-like Viruses from Pigs with a Wasting Disease in the USA and EuropeJournal of Veterinary Diagnostic Investigation, 1998
- Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestineGut, 1973